Self-assembled peptide RADA16 hydrogel supports wound epithelialization by a laminin-332-dependent binding mechanism

Area of Science:

• Biomaterials Science
• Wound Healing Research
• Regenerative Medicine

Background:

• Re-epithelialization is crucial for skin wound repair, but chronic wounds often exhibit impaired healing.
• Existing therapeutics lack specific solutions for promoting re-epithelialization in chronic wounds.
• Self-assembling peptide hydrogels, like RADA16, show potential due to their biocompatibility and tunable properties.

Purpose of the Study:

• To investigate the potential of the RADA16 peptide hydrogel as a therapeutic for promoting skin wound re-epithelialization.
• To elucidate the mechanism by which RADA16 supports epidermal regeneration and wound closure.
• To characterize a suitable RADA16 formulation for enhancing keratinocyte function.

Main Methods:

• Investigated RADA16 hydrogel formulations for their ability to support keratinocyte adhesion, proliferation, and migration in vitro.
• Evaluated the efficacy of RADA16 in promoting wound closure in vivo.
• Determined the specific molecular interactions between RADA16 and key extracellular matrix proteins, particularly laminin-332.

Main Results:

• RADA16 hydrogel effectively supports keratinocyte adhesion, proliferation, and migration, facilitating wound closure.
• The mechanism involves RADA16's specific binding to laminin-332, a critical protein for epidermal cell adhesion.
• RADA16 acts as a synthetic, hydrating, stable, and resorbable scaffold that promotes endogenous re-epithelialization.

Conclusions:

• The RADA16 peptide hydrogel is the first synthetic hydrogel that promotes wound re-epithelialization via a spontaneous laminin-332 binding mechanism.
• RADA16 demonstrates significant potential as a therapeutic agent for accelerating skin wound healing and addressing chronic wound challenges.
• This study provides a mechanistic understanding of RADA16's pro-healing properties, paving the way for clinical applications.